Origin.bio GmbH
Origin.Bio, launched in 2021, connects bioengineers with nature to create synthetic microorganisms for producing ingredients traditionally made through chemical processes.
Introduction
Origin.Bio, launched in 2021, is a pioneering synthetic biology company that bridges the gap between bioengineers and nature. This innovative firm develops synthetic microorganisms capable of producing many of the same ingredients currently manufactured through traditional chemical industrial processes, but with significant...
Information
More Websites
System house offering digital microscopy and cell imaging solutions across biology, medicine, and pharmacy.
Accela was founded in 2007 by US and Chinese bio-pharmaceutical experts.